Quality of Life in Patients With Lung Cancer

Quality of Life in Patients With Lung CancerA Review of Literature From 1970 to 1995
Lung cancer is the most common cancer in the world, accounting for 17.6% of cancers of men worldwide, and 22% of cancers in men in the developed countries. More importantly, in some parts of the world such as Glasgow (Scotland), the age-standardized incidence of lung caner has overtaken that of breast cancer in women.2 Since >80% of lung cancer patients die within a year, the issue of quality of life in this group of patients is paramount.
There are several articles on the subject (22 papers and 2 books). Of these, most are commentaries, one is a symposium agenda, one is a report, one is an article that examines different ways of analyzing the quality of life data, and three are presentation abstracts. The books consist of a number of published articles (already included in this review), and articles about quality of life instruments for use in studies of lung cancer. The remaining articles are reviews. These review articles mainly focus on two issues: review of instruments used, and the effect of disease and its treatment on quality of life of lung cancer patients. All articles suggest that assessment of quality of life should be included in evaluating treatment outcomes. Of these, only two articles include a summary of quality of life studies in lung cancer patients > Some of these review articles have a narrow focus on clinical trials, and none were carried out in a systematic way. The method of review and the criteria for including articles are not identified. In addition, these reviews did not include all published articles at the time they were carried out.
This article reviews the literature on quality of life studies in lung cancer patients and gives an insight into the improvement achieved. The review has been carried out in conjunction with a population-based epidemiologic study on quality of life in lung cancer patients in Glasgow, Scotland. The review consists of three sections. Section 1 includes studies on quality of life in patients with lung cancer coving more general aspects, while sections 2 and 3 include studies of small and non-small cell lung cancer and discuss more specific issues. This distinction was made due to the fact that in the former studies, either the cell type was not identified or different histologic types were included in the studies, whereas in the latter studies, only small or non-small cell lung cancer patients were included in the studies.

Category: Cancer

Tags: chemotherapy, lung cancer, non-small cell lung